| General Overview | |
| Location | South America, with access to the Caribbean and strong cultural ties to both regions. |
| Population | Approximately 620,000 (2024 estimate). |
| Economy | Heavily reliant on natural resources such as gold, oil, and bauxite. Cannabis cultivation for export is emerging as a potential economic opportunity. |
| Cannabis History & Culture | Cannabis remains illegal, though it has been cultivated historically. SE Medical Suriname is pioneering legal medical cannabis cultivation and exportation. |
| Current Legal Status | |
| Personal Use | Cannabis is classified as an illegal substance under Surinamese law. Possession and use are criminalized. |
| Medicinal Use | While cannabis remains broadly illegal, SE Medical Suriname has received government support to produce medical cannabis for export under strict regulations. |
| Recreational Use | Recreational use of cannabis is illegal, with strict penalties for possession, sale, and cultivation. |
| Restrictions | Cannabis cultivation, sale, and possession are illegal except for SE Medical Suriname’s licensed operations. |
| Projected Market Data | |
| Market Size Forecast | Suriname is positioned to become a significant exporter of medical cannabis to Europe and South America, with potential annual revenues in the millions of USD. |
| Licensing Revenue | Revenue from licenses for cultivation and exportation could contribute significantly to Suriname’s economy. |
| Economic Impact | The legal cannabis industry is expected to create jobs, attract foreign investment, and bolster Suriname’s export portfolio. |
| Cannabis Industry & Economy | |
| Key Players | – SE Medical Suriname: Suriname’s largest grower of organic medical cannabis, focusing on export markets. – Government of Suriname: Supports cannabis cultivation initiatives to diversify the economy. |
| Economic Potential | Suriname aims to leverage its agricultural potential and favorable climate to become a leader in organic medical cannabis production and export. |
| Commercial Initiatives | SE Medical Suriname specializes in cultivation, seed production, genetic breeding, and export to licensed global buyers. |
| Research & Development | |
| Academic Partnerships | Limited formal partnerships; opportunities exist for collaboration with international research institutions to enhance cultivation methods and genetic research. |
| Research Focus | SE Medical Suriname conducts cannabis genetic breeding and research, emphasizing organic cultivation methods and CBD-rich strains. |
| Potential Collaborations | Suriname could collaborate with international agronomy experts and pharmaceutical companies to expand its medical cannabis offerings. |
| Cultural & Social Dynamics | |
| Cultural Acceptance | Cannabis use is culturally present but faces legal restrictions. Medical cannabis reform is gaining acceptance. |
| Social Programs | There are no significant cannabis-related social programs. Advocacy for medical cannabis reform is led by private organizations and businesses. |
| Community Impact | Legal cannabis cultivation by SE Medical is creating local jobs and economic opportunities in rural areas. |
| Environment & Sustainability | |
| Agricultural Practices | SE Medical Suriname emphasizes organic cultivation practices, leveraging the region’s high UV index and fertile soil. |
| Environmental Challenges | Balancing cannabis cultivation with the preservation of Suriname’s rich biodiversity remains a priority. |
| Sustainability Initiatives | SE Medical integrates sustainable farming practices and renewable energy solutions into its operations. |
| Challenges & Opportunities | |
| Challenges | – Cannabis remains illegal for personal and recreational use. – Limited infrastructure and regulatory frameworks. – Smuggling and illicit trade issues. |
| Opportunities | – Establishing Suriname as a hub for organic medical cannabis cultivation. – Strengthening export pathways to Europe and South America. – Attracting foreign investment to expand cultivation and processing facilities. |
| Key Recommendations | |
| For Policymakers | – Develop a clear regulatory framework for medical cannabis production and export. – Consider decriminalizing minor cannabis offenses to focus on medical and industrial opportunities. – Promote public education on the benefits of medical cannabis reform. |
| For Investors | – Invest in cultivation and processing facilities for medical cannabis. – Partner with SE Medical Suriname to access international markets. – Explore opportunities in genetic research and cannabis-derived pharmaceuticals. |
| For Communities | – Advocate for transparent cannabis policies that prioritize local economic benefits. – Support community-based farming initiatives to enhance economic inclusion. |
| Licensing | |
| Cultivation License | Licenses issued to SE Medical Suriname for organic cannabis cultivation and research. |
| Dispensary License | Not applicable as cannabis products are not sold domestically. |
| Research License | Focused on genetic breeding, seed production, and cannabinoid research. |
| Export License | SE Medical Suriname exports medical cannabis products to licensed buyers in Europe and South America. |
| Annexes and References | |
| Key Documents | – Surinamese Drug Control Laws. – SE Medical Suriname’s partnership agreements. |
| References | – SE Medical Suriname’s official publications. – International Narcotics Control Strategy Report (2024). – Surinamese Minister of Agriculture statements. |
| Call to Action | Stakeholders and investors are encouraged to contact the International Society of Cannabis (ISC) at investors@is-cannabis.com for guidance on Suriname’s medical cannabis opportunities and strategic partnerships. |
